Drugs · acquisition-cost intelligence
zolpidem tartrate
· ingredient zolpidem· ZOLPIDEM TARTRATE 1.75 mg/1; ZOLPIDEM TARTRATE 3.5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$5.63
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other zolpidem products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Ambien | $0.03392 | −$5.59 |
| Zolpidem | $0.03392 | −$5.59 |
| Ambien CR | $0.11608 | −$5.51 |
| zolpidem tartrate | $7.96 | +$2.33 |
Medicare Part D coverage · CY2026
On 5 plan formularies · typical tier 3
Prior auth 20% · Step therapy 0% · Quantity limit 100% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.